These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26474202)

  • 1. Treating the patient with nonalcoholic fatty liver disease.
    Chaney A
    Nurse Pract; 2015 Nov; 40(11):36-42; quiz 42-3. PubMed ID: 26474202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rising incidence of nonalcoholic fatty liver disease.
    Wisocky J; Paul S
    Nurse Pract; 2017 Jul; 42(7):14-20. PubMed ID: 28562448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Nurse Practitioner in the Management of Nonalcoholic Fatty Liver Disease.
    Hearn C; Ellington BJ; Jones R
    Gastroenterol Nurs; 2018; 41(5):424-426. PubMed ID: 30272604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease.
    Della Corte C; Liccardo D; Ferrari F; Alisi A; Nobili V
    Expert Opin Pharmacother; 2014 Dec; 15(17):2501-11. PubMed ID: 25219959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: What nurses need to know.
    Vacca VM
    Nursing; 2020 Mar; 50(3):32-39. PubMed ID: 32068703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Fatty Liver Disease Management: Dietary and Lifestyle Modifications.
    Nguyen V; George J
    Semin Liver Dis; 2015 Aug; 35(3):318-37. PubMed ID: 26378647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease and statins.
    Tziomalos K; Athyros VG; Paschos P; Karagiannis A
    Metabolism; 2015 Oct; 64(10):1215-23. PubMed ID: 26234727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and Nonalcoholic Fatty Liver Disease.
    Chaney A
    Nurs Clin North Am; 2021 Dec; 56(4):543-552. PubMed ID: 34749893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on nonalcoholic fatty liver disease.
    Provencher DM
    JAAPA; 2014 Jul; 27(7):18-22. PubMed ID: 24901731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the Nurse Practitioner in the Management of Nonalcoholic Fatty Liver Disease.
    Gastroenterol Nurs; 2018; 41(5):E3. PubMed ID: 30272609
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease.
    Pearce L
    Nurs Stand; 2016 Aug; 30(52):15. PubMed ID: 27641564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).
    Fan JG; Wei L; Zhuang H;
    J Dig Dis; 2019 Apr; 20(4):163-173. PubMed ID: 30444584
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of lifestyle interventions in NAFLD (nonalcoholic fatty liver disease) - how are clinical trials affected?
    Michel M; Schattenberg JM
    Expert Opin Investig Drugs; 2020 Feb; 29(2):93-97. PubMed ID: 31933385
    [No Abstract]   [Full Text] [Related]  

  • 16. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    ; LaBrecque DR; Abbas Z; Anania F; Ferenci P; Khan AG; Goh KL; Hamid SS; Isakov V; Lizarzabal M; Peñaranda MM; Ramos JF; Sarin S; Stimac D; Thomson AB; Umar M; Krabshuis J; LeMair A;
    J Clin Gastroenterol; 2014 Jul; 48(6):467-73. PubMed ID: 24921212
    [No Abstract]   [Full Text] [Related]  

  • 17. Leptin in nonalcoholic fatty liver disease: a narrative review.
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2015 Jan; 64(1):60-78. PubMed ID: 25456097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
    Luo J; Xu L; Li J; Zhao S
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Nobili V; Alkhouri N; Alisi A; Della Corte C; Fitzpatrick E; Raponi M; Dhawan A
    JAMA Pediatr; 2015 Feb; 169(2):170-6. PubMed ID: 25506780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.